Clinical Trial Results:
A randomized, double blind, placebo and active controlled, parallel group
study to evaluate the safety and efficacy of 6-week treatment with oral doses of
50 mg b.i.d., 200 mg b.i.d., and 400 mg b.i.d. BI 671800 ED in steroid-naïve
patients with persistent asthma
Summary
|
|
EudraCT number |
2010-023326-20 |
Trial protocol |
LV EE |
Global completion date |
26 May 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Jul 2018
|
First version publication date |
08 Jul 2018
|
Other versions |
|
Summary report(s) |
Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.